Skip to main content

Table 1 Baseline characteristics of the study cohort, stratified by albuminuria status. Data represent means ± SD unless a percentage (%) is stated

From: Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus

Baseline variable

Everyone (n = 54,801)

Normoalbuminuria (n = 42,662)

Albuminuria (n = 12,139)

p value*

Men, n (%)

30,164 (55.0%)

23,611 (55.3%)

6553 (54.0%)

0.081

Age (years)

67.4 ± 11.9

66.8 ± 11.8

69.4 ± 12.2

< 0.001

BMI (kg/m2)

29.7 ± 5.9

29.7 ± 5.9

29.8 ± 6.2

0.135

SBP (mmHg)

138.4 ± 16.9

137.7 ± 16.4

140.8 ± 18.4

< 0.001

Total: HDL cholesterol ratio

3.8 ± 1.2

3.8 ± 1.2

3.8 ± 1.2

0.423

HbA1c (mmol/mol)

56.9 ± 15.3

56.1 ± 14.7

59.6 ± 17.0

< 0.001

Never smoked, n (%)

13,308 (24.3%)

10,499 (24.6%)

2809 (23.1%)

< 0.001

Ex-smokers, n (%)

28,755 (52.5%)

22,604 (53.0%)

6151 (50.7%)

Current smokers, n (%)

12,738 (23.2%)

9559 (22.4%)

3179 (26.2%)

  1. *Adjusted for multiple comparisons using Bonferroni’s method